IHC breast examination - transcript

Immunohistochemical research (IHC) is a method of studying the glandular tissue of the breast, in which a special reagent is used to obtain a complete cell characterization:

The analysis of IHC of the breast is assigned both for suspicion of the oncological process and for its course, in order to diagnose the effectiveness of the chemotherapeutic treatment.

What makes it possible to determine IGH?

To begin with, it is necessary to say that the deciphering of the result of the IHC of breast research should be done exclusively by the doctor. Only he, knowing fully the features of the course of the disease, can interpret the result obtained.

IHC, conducted in breast cancer, determines the nature of the tumor. Most often with IHC of the breast, the definition of receptors is used:

It was found that a tumor containing a large number of these receptors behaves non-aggressively, is inactive. When treating this form, hormone therapy is very effective. Favorable prognosis in 75% of cases.

When deciphering the results of analysis of IHC of the breast, percentage units of measurement are used. This determines the ratio of the number of cells with expression (susceptibility) to estrogens and progesterone, the total number of tumor cells. In this case, the result is deduced as the ratio of the number of nuclei of the stained cells to unpainted, in aggregate to 100 cells.

In view of the complexity of such calculations of their interpretation, the evaluation of the result is done exclusively by specialists.